| # | Drug | Count |
|---|---|---|
| 0 | AMIKACIN | 22 |
| 1 | PEMBROLIZUMAB | 20 |
| 2 | CARBOPLATIN | 11 |
| 3 | ALBUTEROL SULFATE | 10 |
| 4 | RISANKIZUMAB-RZAA | 10 |
| 5 | UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 10 |
| 6 | AZITHROMYCIN | 9 |
| 7 | AZITHROMYCIN DIHYDRATE | 9 |
| 8 | AZITHROMYCIN MONOHYDRATE | 9 |
| 9 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ILOPROST | 2 | 0.0021 |
| 1 | PLATINUM | 1 | 0.0019 |
| 2 | CROTAMITON | 1 | 0.0016 |
| 3 | TEPOTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 4 | INTERFERON GAMMA-1B | 2 | 0.0014 |
| 5 | AMIKACIN | 22 | 0.0013 |
| 6 | CYCLOSERINE | 2 | 0.0009 |
| 7 | PENTAMIDINE ISETHIONATE | 1 | 0.0008 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 6 | 0.0007 |
| 9 | GIVOSIRAN SODIUM | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 25 |
| 1 | Aminoglycoside Antibacterial [EPC] | 24 |
| 2 | Platinum-based Drug [EPC] | 15 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 4 | Kinase Inhibitor [EPC] | 11 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| 6 | Azole Antifungal [EPC] | 10 |
| 7 | Benzodiazepine [EPC] | 10 |
| 8 | Corticosteroid [EPC] | 10 |
| 9 | Interleukin-23 Antagonist [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Prostacycline [EPC] | 2 | 0.0021 |
| 2 | Interferon gamma [EPC] | 2 | 0.0014 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Aminoglycoside Antibacterial [EPC] | 24 | 0.0005 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 6 | 0.0005 |
| 6 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 9 | Oxazolidinone Antibacterial [EPC] | 8 | 0.0003 |